Giovanni Mariggi
InvestorFounderCo-founder and Partner at Medicxi · Board director at Illexcor Therapeutics · Board director at FORE US Bio
Geneva
About
Giovanni Mariggi co-founded a biotech venture firm after pioneering asset‑centric investing—concentrating teams around single high‑conviction drug assets—and takes a hands‑on vaccine company‑building role, chairing ViceBio and serving on Curevo's board.
Invests in
BiotechDigital HealthHealthtechMedical Devices
Board director at Illexcor Therapeutics
Intro paths
In turn, Giovanni can intro founders to Illexcor Therapeutics's investors below.
Illexcor Therapeutics's investors · 1
Board director at FORE US Bio
Intro paths
In turn, Giovanni can intro founders to FORE US Bio's investors below.
Experience
- medicxiPartnercurrent2018 — presentLondon Area, United Kingdom
- medicxiPrincipal2016 — 2018London Area, United Kingdom
- Index VenturesPrincipal - Life Sciences2015 — 2016Geneva, Geneva, Switzerland
- Index VenturesAssociate - Life Sciences2012 — 2014Geneva, Geneva, Switzerland
- Cancer Research UKPhD Student2007 — 2011London Area, United Kingdom
- Deallus GroupConsultant2011London Area, United Kingdom
- Merck SeronoIndustry Placement2005 — 2006Geneva, Geneva, Switzerland
Education
- UCLPhD, Biochemistry and Molecular Biology2007 — 2011
- Imperial College LondonBSc with year in Industry, Biochemistry2003 — 2007
- Aiglon CollegeGCSEs & A-Levels1995 — 2003
Skills & more
Languages English · French · Italian
From Giovanni's professional profile.
Deals · 4
Illexcor TherapeuticsBoard seat
via Medicxi · filed May 2026 · $69M raise
FORE US BioBoard seat
via Medicxi · filed May 2025 · $46M raise
CurevoLed round
via Medicxi · filed Mar 2025 · $84.8M raise
VicebioLed round
via Medicxi
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Led
AbivaxAura BiosciencesNew Amsterdam
Board seats
Breakpoint TherapeuticsForeBioVaderis Therapeutics
Sources: the firm's website · SEC Form D filings.
Colleagues at Medicxi
Frequently asked questions
- Who is Giovanni Mariggi?
- Giovanni Mariggi co-founded a biotech venture firm after pioneering asset‑centric investing—concentrating teams around single high‑conviction drug assets—and takes a hands‑on vaccine company‑building role, chairing ViceBio and serving on Curevo's board.
- Where does Giovanni Mariggi work?
- Giovanni Mariggi is Co-founder and Partner at Medicxi and Board director at Illexcor Therapeutics and Board director at FORE US Bio.
- What does Giovanni Mariggi invest in?
- Giovanni Mariggi invests in Biotech, Digital Health, Healthtech, Medical Devices.
- What boards does Giovanni Mariggi sit on?
- Giovanni Mariggi holds tracked board seats at Breakpoint Therapeutics, Curevo, FORE US Bio, ForeBio, Illexcor Therapeutics, Vaderis Therapeutics.
- What companies has Giovanni Mariggi invested in?
- Investments tracked here include Abivax, Aura Biosciences, Curevo, New Amsterdam, Vicebio.
- Where did Giovanni Mariggi go to school?
- Giovanni Mariggi studied at UCL (PhD, Biochemistry and Molecular Biology); Imperial College London (BSc with year in Industry, Biochemistry); Aiglon College (GCSEs & A-Levels).
- Does Giovanni Mariggi lead rounds?
- Yes — Giovanni Mariggi has led 5 tracked investments.
Same school
Also attended UCL383
+ 377 more
Shared employers
Also worked at medicxi23
+ 17 more
Also worked at Index Ventures122
+ 116 more
Also worked at Cancer Research UK21
+ 15 more
Also worked at Deallus Group7
+ 1 more